Literature DB >> 11163457

Treatment of acute otitis media - challenges in the era of antibiotic resistance.

R Dagan1.   

Abstract

The last decade is characterized by the increase in antibiotic resistance among respiratory bacterial pathogens in the presence of only modest progress in the development of new antibacterial agents to overcome this resistance. A series of recent studies show clearly that the increased resistance among the main AOM pathogens (namely Streptococcus pneumoniae and Haemophilus influenzae) is associated with a dramatic decrease in bacteriologic response to antibiotic treatment, which in turn has an impact on clinical response. Thus, the individual patient is affected by the increasing antibiotic resistance. Moreover, the society as a whole is now also affected because the carriage and spread of antibiotic resistant AOM pathogens is remarkably impacted by antibiotic treatment. New studies show the remarkable ability of antibiotics to rapidly promote nasopharyngeal carriage and spread of antibiotic-resistant AOM pathogens. In these studies, the increase in carriage of antibiotic resistant S. pneumoniae is shown already after 3-4 days from initiation of antibiotic treatment and may last for weeks to months after treatment. Children carrying antibiotic-resistant organisms transmit those organisms to their family and to their day care centers and thus a vicious cycle is created in which increased antibiotic resistance with decreased response leads to increased antibiotic use, which in turn leads to further increase in resistance. New antibiotics are not likely to improve this situation. It is clear that the challenge in the next decade is to prevent AOM rather than to treat it. Efforts to prevent AOM include improved environmental factors, immunization with bacterial and viral vaccines and some creative measures such as prevention of colonization and attachment to epithelium of AOM pathogens. Whether these efforts will prove successful or, even if successful, will only modify the clinical and bacteriologic picture presenting new challenges, only time will tell.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11163457     DOI: 10.1016/s0264-410x(00)00272-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Pneumonia research to reduce childhood mortality in the developing world.

Authors:  J Anthony G Scott; W Abdullah Brooks; J S Malik Peiris; Douglas Holtzman; E Kim Mulholland
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model.

Authors:  Hazeline Roche; Anders Håkansson; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?

Authors:  Ron Dagan; Galia Barkai; Noga Givon-Lavi; Amir Z Sharf; Daniel Vardy; Ted Cohen; Marc Lipsitch; David Greenberg
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

4.  Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera.

Authors:  Kristin Furano; Anthony A Campagnari
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Community prescribing and resistant Streptococcus pneumoniae.

Authors:  Galia Barkai; David Greenberg; Noga Givon-Lavi; Eli Dreifuss; Daniel Vardy; Ron Dagan
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

6.  Haemophilus haemolyticus Interaction with Host Cells Is Different to Nontypeable Haemophilus influenzae and Prevents NTHi Association with Epithelial Cells.

Authors:  Janessa L Pickering; Amy Prosser; Karli J Corscadden; Camilla de Gier; Peter C Richmond; Guicheng Zhang; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Front Cell Infect Microbiol       Date:  2016-05-09       Impact factor: 5.293

7.  Drug Resistance Characteristics and Macrolide-Resistant Mechanisms of Streptococcus pneumoniae in Wenzhou City, China.

Authors:  Dakang Hu; Zheng Sun; Xinhua Luo; Shuangchun Liu; Lianhua Yu; Ying Qu; Jinhong Yang; Jian Yu; Xiangyang Li; Jin Zhang
Journal:  Med Sci Monit       Date:  2016-08-02

8.  Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media.

Authors:  Jun Shimada; Sung K Moon; Haa-Yung Lee; Tamotsu Takeshita; Huiqi Pan; Jeong-Im Woo; Robert Gellibolian; Noboru Yamanaka; David J Lim
Journal:  BMC Infect Dis       Date:  2008-10-08       Impact factor: 3.090

9.  Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.

Authors:  Haa-Yung Lee; Ali Andalibi; Paul Webster; Sung-Kyun Moon; Karen Teufert; Sung-Ho Kang; Jian-Dong Li; Mitsuyoshi Nagura; Tomas Ganz; David J Lim
Journal:  BMC Infect Dis       Date:  2004-05-05       Impact factor: 3.090

10.  Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells.

Authors:  Haa-Yung Lee; Tamotsu Takeshita; Jun Shimada; Arsen Akopyan; Jeong-Im Woo; Huiqi Pan; Sung K Moon; Ali Andalibi; Rae-Kil Park; Sung-Ho Kang; Shin-Seok Kang; Robert Gellibolian; David J Lim
Journal:  BMC Infect Dis       Date:  2008-06-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.